Safety and efficacy of oral antiplatelet for patients who had acute ischaemic stroke undergoing endovascular therapy.

Xiaochuan HuoRaynald RaynaldJing JingAnxin WangDapeng MoFeng GaoNing MaYilong WangYongjun WangZhongrong Miao

Published in: Stroke and vascular neurology (2020)

Oral APT prior to undergoing EVT is safe and may accompany with superior clinical outcomes. DAPT may associate with superior clinical outcomes and lower risk of mortality.

Keyphrases

liver failure
aortic dissection
respiratory failure
cardiovascular events
antiplatelet therapy
risk factors
drug induced
type diabetes
stem cells
intensive care unit
cell therapy
bone marrow
hepatitis b virus
replacement therapy